Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Axon degeneration in Parkinson's disease.
Burke RE, O'Malley K.
Exp Neurol. 2012 Jan 18. [Epub ahead of print]
Related citations
The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain.
Domenger D, Dea D, Theroux L, Moquin L, Gratton A, Poirier J.
Exp Neurol. 2012 Jan;233(1):513-22. Epub 2011 Dec 3.
A gamma band specific role of the subthalamic nucleus in switching during verbal fluency tasks in Parkinson's disease.
Anzak A, Gaynor L, Beigi M, Limousin P, Hariz M, Zrinzo L, Foltynie T, Brown P, Jahanshahi M.
Exp Neurol. 2011 Dec;232(2):136-42. Epub 2011 Aug 18.
Parkinson's disease and pathological oscillatory activity: is the beta band the bad guy? - New lessons learned from low-frequency deep brain stimulation.
Timmermann L, Florin E.
Exp Neurol. 2012 Jan;233(1):123-5. Epub 2011 Oct 29.
GABA-B receptor: possible target for Parkinson's disease therapy.
Nambu A.
Exp Neurol. 2012 Jan;233(1):121-2. Epub 2011 Oct 25. No abstract available.
The role of the sub-thalamic nucleus in the preparation of volitional movement termination in Parkinson's disease.
Hsu YT, Lai HY, Chang YC, Chiou SM, Lu MK, Lin YC, Liu YL, Chen CC, Huang HC, Chien TF, Lin SZ, Chen YY, Tsai CH.
Exp Neurol. 2012 Jan;233(1):253-63. Epub 2011 Oct 21.
Do we still need to develop new imaging biomarkers of dopamine denervation for Parkinson's disease?
Pavese N.
Exp Neurol. 2012 Jan;233(1):118-20. Epub 2011 Oct 20. No abstract available.
Stress, depression and Parkinson's disease.
Hemmerle AM, Herman JP, Seroogy KB.
Exp Neurol. 2012 Jan;233(1):79-86. Epub 2011 Oct 6. Review.
l-DOPA is incorporated into brain proteins of patients treated for Parkinson's disease, inducing toxicity in human neuroblastoma cells in vitro.
Chan SW, Dunlop RA, Rowe A, Double KL, Rodgers KJ.
Exp Neurol. 2011 Oct 1. [Epub ahead of print]
External pallidal stimulation improves parkinsonian motor signs and modulates neuronal activity throughout the basal ganglia thalamic network.
Vitek JL, Zhang J, Hashimoto T, Russo GS, Baker KB.
Exp Neurol. 2012 Jan;233(1):581-6. Epub 2011 Oct 1.
Return of bradykinesia after subthalamic stimulation ceases: relationship to electrode location.
Cooper SE, Noecker AM, Abboud H, Vitek JL, McIntyre CC.
Exp Neurol. 2011 Oct;231(2):207-13. Epub 2011 Jun 25.
Insulin resistance impairs nigrostriatal dopamine function.
Morris JK, Bomhoff GL, Gorres BK, Davis VA, Kim J, Lee PP, Brooks WM, Gerhardt GA, Geiger PC, Stanford JA.
Exp Neurol. 2011 Sep;231(1):171-80. Epub 2011 Jun 15.
Circadian dysfunction in a mouse model of Parkinson's disease.
Kudo T, Loh DH, Truong D, Wu Y, Colwell CS.
Exp Neurol. 2011 Nov;232(1):66-75. Epub 2011 Aug 16.
5-HT(1A) receptor stimulation and L-DOPA-induced dyskinesia in Parkinson's disease: bridging the gap between serotonergic and glutamatergic mechanisms.
Huot P, Brotchie JM.
Exp Neurol. 2011 Oct;231(2):195-8. Epub 2011 Jul 30. No abstract available.
Effect of globus pallidus internus stimulation on neuronal activity in the pedunculopontine tegmental nucleus in the primate model of Parkinson's disease.
Zhang J, Wang ZI, Baker KB, Vitek JL.
Exp Neurol. 2012 Jan;233(1):575-80. Epub 2011 Jul 29.
Pallidal stimulation: effect of pattern and rate on bradykinesia in the non-human primate model of Parkinson's disease.
Baker KB, Zhang J, Vitek JL.
Exp Neurol. 2011 Oct;231(2):309-13. Epub 2011 Jul 1.
Deep brain stimulation of the subthalamic nucleus transiently enhances loss-chasing behaviour in patients with Parkinson's disease.
Rogers RD, Wielenberg B, Wojtecki L, Elben S, Campbell-Meiklejohn D, Schnitzler A.
Exp Neurol. 2011 Sep;231(1):181-9. Epub 2011 Jun 25.
Stimulation of the subthalamic region at 20 Hz slows the development of grip force in Parkinson's disease.
Chen CC, Lin WY, Chan HL, Hsu YT, Tu PH, Lee ST, Chiou SM, Tsai CH, Lu CS, Brown P.
Exp Neurol. 2011 Sep;231(1):91-6. Epub 2011 Jun 13.
Subthalamic deep brain stimulation increases pallidal firing rate and regularity.
Reese R, Leblois A, Steigerwald F, Pötter-Nerger M, Herzog J, Mehdorn HM, Deuschl G, Meissner WG, Volkmann J.
Exp Neurol. 2011 Jun;229(2):517-21. Epub 2011 Feb 15.
Levodopa and Parkinson disease--electrophysiological perspectives in animal models.
Rahimi F, Typlt M, Jog MS.
Exp Neurol. 2011 Sep;231(1):11-3. Epub 2011 May 27. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on